Actionable news
All posts from Actionable news
Actionable news in RVNC: REVANCE THERAPEUTICS Inc,

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Revance Therapeutics, Inc. - RVNC

NEW YORK, June 11, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 237.

The investigation concerns whether Revance and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On June 10, 2015, a Class Action lawsuit filed against the company alleges that the Registration...